Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study

An estimated 1.5 million Kenyans are HIV-seropositive, with 1.1 million on antiretroviral therapy (ART), with the majority of them unaware of their drug resistance status. In this study, we assessed the prevalence of drug resistance to nucleoside reverse transcriptase inhibitors (NRTIs), nucleoside...

Descripción completa

Detalles Bibliográficos
Autores principales: Scriven, Yvonne A., Mulinge, Martin M., Saleri, Norah, Luvai, Elizabeth A., Nyachieo, Atunga, Maina, Esther N., Mwau, Matilu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500620/
https://www.ncbi.nlm.nih.gov/pubmed/34622871
http://dx.doi.org/10.1097/MD.0000000000027460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500620/
https://www.ncbi.nlm.nih.gov/pubmed/34622871
http://dx.doi.org/10.1097/MD.0000000000027460

Ejemplares similares